PLRX PLIANT THERAPEUTICS, INC.
Nasdaq · SEC CIK 1746473 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $163.6K 4 sales by 4 insiders
- Filings on record
- 150 since 2021-07-01, latest 2026-07-13 16:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Coulie Bernard | Pres, CEO, Dir | — | $114.4K |
| Cummings Keith Lamont | CFO | — | $30.7K |
| Cheung Lily | Chief Human Resource Off | — | $9,644 |
| Kuo Minnie | COO | — | $8,854 |
Transactions 108
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-22 | 2026-01-20 | PLRX | Kuo Minnie | COO | S - Sale | $1.28 | -6,917 | 37.8K | -15% | -$8,854 | |
| 2026-01-22 | 2026-01-20 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $1.28 | -24.0K | 297.2K | -7% | -$30.7K | |
| 2026-01-22 | 2026-01-20 | PLRX | Cheung Lily | Chief Human Resource Off | S - Sale | $1.28 | -7,534 | 44.8K | -14% | -$9,644 | |
| 2026-01-22 | 2026-01-20 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale | $1.28 | -89.4K | 505.6K | -15% | -$114.4K | |
| D | 2025-01-27 | 2025-01-23 | PLRX | Cheung Lily | Chief Human Resource Off | A - Grant | $0.00 | +25.9K | 50.4K | +105% | $0 |
| D | 2025-01-27 | 2025-01-23 | PLRX | Lefebvre Eric | Chief Medical Off | A - Grant | $0.00 | +45.6K | 240.2K | +23% | $0 |
| D | 2025-01-27 | 2025-01-23 | PLRX | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +162.5K | 593.0K | +38% | $0 |
| D | 2025-01-27 | 2025-01-23 | PLRX | Hull Hans | Chief Business Off | A - Grant | $0.00 | +40.1K | 251.7K | +19% | $0 |
| D | 2025-01-27 | 2025-01-23 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +35.0K | 105.5K | +50% | $0 |
| D | 2025-01-27 | 2025-01-23 | PLRX | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +56.6K | 319.3K | +22% | $0 |
| 2025-01-22 | 2025-01-17 | PLRX | Hull Hans | Chief Business Off | S - Sale | $11.20 | -15.9K | 211.6K | -7% | -$178.5K | |
| 2025-01-22 | 2025-01-17 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale | $11.20 | -52.4K | 430.5K | -11% | -$587.1K | |
| 2025-01-22 | 2025-01-17 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $11.20 | -18.5K | 194.6K | -9% | -$207.0K | |
| 2025-01-22 | 2025-01-17 | PLRX | Cheung Lily | Chief Human Resource Off | S - Sale | $11.20 | -3,740 | 24.6K | -13% | -$41.9K | |
| M | 2025-01-22 | 2025-01-17+ | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $11.11 | -23.5K | 70.5K | -25% | -$261.1K |
| 2025-01-22 | 2025-01-17 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $11.20 | -20.1K | 262.6K | -7% | -$225.7K | |
| 2024-07-12 | 2024-07-10 | PLRX | Hull Hans | Chief Business Off | S - Sale | $11.56 | -9,900 | 227.5K | -4% | -$114.4K | |
| 2024-07-12 | 2024-07-10 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $11.56 | -10.9K | 282.1K | -4% | -$126.1K | |
| 2024-07-12 | 2024-07-10 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $11.56 | -12.3K | 213.1K | -5% | -$142.4K | |
| 2024-07-12 | 2024-07-10 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $11.56 | -7,656 | 94.0K | -8% | -$88.5K | |
| 2024-07-12 | 2024-07-10 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale | $11.56 | -38.7K | 482.9K | -7% | -$447.5K | |
| 2024-07-11 | 2024-07-09 | PLRX | Hull Hans | Chief Business Off | A - Grant | $0.00 | +19.3K | 237.4K | +9% | $0 | |
| 2024-07-11 | 2024-07-09 | PLRX | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +21.3K | 293.0K | +8% | $0 | |
| 2024-07-11 | 2024-07-09 | PLRX | Lefebvre Eric | Chief Medical Off | A - Grant | $0.00 | +24.1K | 225.4K | +12% | $0 | |
| 2024-07-11 | 2024-07-09 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +15.0K | 101.7K | +17% | $0 | |
| 2024-07-11 | 2024-07-09 | PLRX | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +75.6K | 521.6K | +17% | $0 | |
| D | 2024-05-06 | 2024-05-02 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +21.0K | 271.7K | +8% | +$43.7K |
| D | 2024-01-24 | 2024-01-23 | PLRX | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +128.2K | 444.5K | +41% | $0 |
| D | 2024-01-24 | 2024-01-23 | PLRX | Cheung Lily | Chief Human Resource Off | A - Grant | $0.00 | +26.0K | 26.8K | +3,270% | $0 |
| D | 2024-01-24 | 2024-01-23 | PLRX | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +55.2K | 249.9K | +28% | $0 |
| D | 2024-01-24 | 2024-01-23 | PLRX | Hull Hans | Chief Business Off | A - Grant | $0.00 | +31.5K | 216.6K | +17% | $0 |
| D | 2024-01-24 | 2024-01-23 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +31.5K | 86.7K | +57% | $0 |
| D | 2024-01-24 | 2024-01-23 | PLRX | Lefebvre Eric | Chief Medical Off | A - Grant | $0.00 | +42.9K | 199.8K | +27% | $0 |
| 2024-01-19 | 2024-01-17 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $17.23 | -5,197 | 55.2K | -9% | -$89.5K | |
| 2024-01-19 | 2024-01-17 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $17.23 | -9,781 | 194.6K | -5% | -$168.5K | |
| 2024-01-19 | 2024-01-17 | PLRX | Hull Hans | Chief Business Off | S - Sale | $17.23 | -9,786 | 185.1K | -5% | -$168.6K | |
| 2024-01-19 | 2024-01-17 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale | $17.23 | -25.7K | 316.4K | -8% | -$443.2K | |
| 2024-01-19 | 2024-01-17 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $17.23 | -10.3K | 156.9K | -6% | -$177.4K | |
| DM | 2023-08-07 | 2023-08-03+ | PLRX | Hull Hans | Chief Business Off | S - Sale+OE | $20.01 | -31.3K | 206.1K | -13% | -$626.6K |
| DM | 2023-08-07 | 2023-08-03+ | PLRX | Hull Hans | Chief Business Off | M - OptEx | $2.08 | +10.6K | 207.9K | +5% | +$22.0K |
| 2023-07-21 | 2023-07-20 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $17.55 | -4,755 | 60.4K | -7% | -$83.5K | |
| 2023-07-19 | 2023-07-17 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $18.01 | -12.8K | 65.2K | -16% | -$230.1K | |
| 2023-07-19 | 2023-07-17 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale | $18.01 | -70.2K | 342.1K | -17% | -$1.26M | |
| 2023-07-19 | 2023-07-17 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $18.01 | -19.8K | 204.0K | -9% | -$356.1K | |
| 2023-07-19 | 2023-07-17 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $18.01 | -22.3K | 167.2K | -12% | -$402.0K | |
| 2023-07-19 | 2023-07-17 | PLRX | Hull Hans | Chief Business Off | S - Sale | $18.01 | -17.9K | 219.2K | -8% | -$323.0K | |
| 2023-07-18 | 2023-07-14 | PLRX | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +137.5K | 412.3K | +50% | $0 | |
| 2023-07-18 | 2023-07-14 | PLRX | Hull Hans | Chief Business Off | A - Grant | $0.00 | +35.2K | 237.1K | +17% | $0 | |
| 2023-07-18 | 2023-07-14 | PLRX | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +38.8K | 223.8K | +21% | $0 | |
| 2023-07-18 | 2023-07-14 | PLRX | Lefebvre Eric | Chief Medical Off | A - Grant | $0.00 | +43.8K | 189.5K | +30% | $0 | |
| 2023-07-18 | 2023-07-14 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +27.2K | 78.0K | +54% | $0 | |
| D | 2023-06-14 | 2023-06-13 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +30.8K | 185.0K | +20% | +$64.0K |
| D | 2023-06-12 | 2023-06-09 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +5,800 | 154.3K | +4% | +$12.1K |
| 2023-04-03 | 2023-03-30 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale | $26.52 | -35.3K | 274.8K | -11% | -$937.2K | |
| 2023-04-03 | 2023-03-30 | PLRX | Hull Hans | Chief Business Off | S - Sale | $26.52 | -9,036 | 202.0K | -4% | -$239.6K | |
| 2023-04-03 | 2023-03-30 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $26.52 | -9,960 | 148.5K | -6% | -$264.1K | |
| M | 2023-04-03 | 2023-03-30+ | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $26.62 | -7,751 | 53.7K | -13% | -$206.3K |
| 2023-04-03 | 2023-03-30 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $26.52 | -11.2K | 145.8K | -7% | -$298.2K | |
| 2023-03-31 | 2023-03-29 | PLRX | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +19.4K | 158.4K | +14% | $0 | |
| 2023-03-31 | 2023-03-29 | PLRX | Hull Hans | Chief Business Off | A - Grant | $0.00 | +17.6K | 211.0K | +9% | $0 | |
| 2023-03-31 | 2023-03-29 | PLRX | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +68.7K | 310.1K | +28% | $0 | |
| 2023-03-31 | 2023-03-29 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +13.6K | 58.5K | +30% | $0 | |
| 2023-03-31 | 2023-03-29 | PLRX | Lefebvre Eric | Chief Medical Off | A - Grant | $0.00 | +21.9K | 157.0K | +16% | $0 | |
| DM | 2023-02-06 | 2023-02-02+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $33.92 | -30.0K | 245.4K | -11% | -$1.02M |
| DM | 2023-02-06 | 2023-02-02+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $6.22 | +30.0K | 255.1K | +13% | +$186.6K |
| DM | 2023-02-01 | 2023-01-30+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $3.87 | +45.0K | 255.1K | +21% | +$174.2K |
| DM | 2023-02-01 | 2023-01-30+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $34.48 | -45.0K | 243.7K | -16% | -$1.55M |
| D | 2023-01-27 | 2023-01-25 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +39.0K | 44.9K | +656% | $0 |
| DM | 2023-01-27 | 2023-01-26+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +30.0K | 255.1K | +13% | +$62.4K |
| DM | 2023-01-27 | 2023-01-26+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $35.49 | -30.0K | 240.1K | -11% | -$1.06M |
| DMI | 2023-01-27 | 2023-01-26+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $35.11 | -25.0K | 409.5K | -6% | -$877.7K |
| D | 2023-01-27 | 2023-01-25 | PLRX | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +146.3K | 240.1K | +156% | $0 |
| D | 2023-01-27 | 2023-01-25 | PLRX | Hull Hans | Chief Business Off | A - Grant | $0.00 | +54.0K | 192.2K | +39% | $0 |
| D | 2023-01-27 | 2023-01-25 | PLRX | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +54.0K | 138.4K | +64% | $0 |
| D | 2023-01-27 | 2023-01-25 | PLRX | Lefebvre Eric | Chief Medical Off | A - Grant | $0.00 | +57.0K | 133.9K | +74% | $0 |
| DM | 2023-01-25 | 2023-01-23 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $4.50 | +30.0K | 96.9K | +45% | +$134.8K |
| D | 2023-01-25 | 2023-01-23 | PLRX | Cummings Keith Lamont | CFO | S - Sale+OE | $35.00 | -30.0K | 84.4K | -26% | -$1.05M |
| DM | 2023-01-25 | 2023-01-23 | PLRX | Ouimette Mike | GC, Corp. Sec'y | M - OptEx | $18.09 | +20.0K | 25.9K | +336% | +$361.8K |
| D | 2023-01-25 | 2023-01-23 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale+OE | $34.19 | -20.0K | 5,947 | -77% | -$683.8K |
| 2023-01-25 | 2023-01-23 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $34.48 | -67.5K | 76.9K | -47% | -$2.33M | |
| DM | 2023-01-25 | 2023-01-23+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +45.0K | 108.8K | +71% | +$93.6K |
| DM | 2023-01-25 | 2023-01-23+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $32.50 | -45.0K | 98.7K | -31% | -$1.46M |
| DI | 2023-01-25 | 2023-01-23 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $35.00 | -15.0K | 434.3K | -3% | -$525.0K |
| DM | 2023-01-09 | 2023-01-06+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +20.0K | 108.8K | +23% | +$41.6K |
| DM | 2023-01-09 | 2023-01-06+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $19.07 | -20.0K | 93.8K | -18% | -$381.5K |
| DM | 2023-01-05 | 2023-01-03+ | PLRX | Coulie Bernard | Pres, CEO, Dir | M - OptEx | $2.08 | +30.0K | 108.8K | +38% | +$62.4K |
| DM | 2023-01-05 | 2023-01-03+ | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale+OE | $19.20 | -30.0K | 93.8K | -24% | -$575.9K |
| D | 2022-12-27 | 2022-12-22 | PLRX | Cummings Keith Lamont | CFO | M - OptEx | $2.08 | +4,000 | 84.4K | +5% | +$8,320 |
| 2022-12-23 | 2022-12-22 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $19.38 | -2,928 | 5,947 | -33% | -$56.7K | |
| 2022-12-21 | 2022-12-19 | PLRX | Hull Hans | Chief Business Off | A - Grant | $0.00 | +17.6K | 146.9K | +14% | $0 | |
| 2022-12-21 | 2022-12-20 | PLRX | Hull Hans | Chief Business Off | S - Sale | $19.10 | -8,748 | 138.2K | -6% | -$167.1K | |
| 2022-12-21 | 2022-12-19 | PLRX | Cummings Keith Lamont | CFO | A - Grant | $0.00 | +19.4K | 90.1K | +27% | $0 | |
| 2022-12-21 | 2022-12-20 | PLRX | Cummings Keith Lamont | CFO | S - Sale | $19.10 | -9,643 | 80.4K | -11% | -$184.2K | |
| 2022-12-21 | 2022-12-20 | PLRX | Coulie Bernard | Pres, CEO, Dir | S - Sale | $19.10 | -34.2K | 93.8K | -27% | -$653.4K | |
| 2022-12-21 | 2022-12-19 | PLRX | Coulie Bernard | Pres, CEO, Dir | A - Grant | $0.00 | +68.8K | 128.0K | +116% | $0 | |
| 2022-12-21 | 2022-12-19 | PLRX | Lefebvre Eric | Chief Medical Off | A - Grant | $0.00 | +21.9K | 155.3K | +16% | $0 | |
| 2022-12-21 | 2022-12-20 | PLRX | Lefebvre Eric | Chief Medical Off | S - Sale | $19.10 | -10.9K | 144.4K | -7% | -$207.9K | |
| 2022-12-21 | 2022-12-19 | PLRX | Ouimette Mike | GC, Corp. Sec'y | A - Grant | $0.00 | +13.6K | 13.6K | New | $0 | |
| 2022-12-21 | 2022-12-20 | PLRX | Ouimette Mike | GC, Corp. Sec'y | S - Sale | $19.10 | -4,719 | 8,875 | -35% | -$90.1K | |
| 2022-12-01 | 2022-11-29 | PLRX | Third Rock Ventures III, L.P. | 10% | J - Other | — | -2.00M | 1.84M | -52% | — |
Purchase Sale Sale after option exercise All abbreviations